Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220326054351N1Phase 3Completed
Phase 3 trial of theophylline in nephrotoxicity, sponsored by Sabzevar University of Medical Sciences. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220326054351N1.